Register D | Generated 2026-04-26 | Intel supply-chain swarm — Skill 3 of 4 > Sources: 2026 proxy (DEF 14A), Form 4 filings, SEC EDGAR, earnings transcripts, public records
Register D | Generated 2026-04-26 | Intel supply-chain swarm — Skill 3 of 4 Sources: 2026 proxy (DEF 14A), Form 4 filings, SEC EDGAR, earnings transcripts, public records
Age: ~55 Tenure as CEO: Since 2015 (Rudolph Technologies); Onto Innovation CEO from merger inception October 2019. Longest-serving CEO in the process control metrology space.
Education: B.S. Computer Science, University of Massachusetts. Advanced Management Program, Harvard Business School.
Career trajectory: - 1999-2003: Founder and President, Counterpoint Solutions Inc. — semiconductor data analysis startup. Founded it himself; sold to August Technology Corporation in 2003 for approximately $1.45M (an exit, but a modest one by industry standards). - 2003-2006: VP Engineering and Director of Strategic Marketing, August Technology. Stayed through the acquisition; built the data analysis and review product line. - 2006-2014: VP and General Manager, Data Analysis and Review Business Unit, Rudolph Technologies (post-merger of August Technology into Rudolph). - 2014-2015: Executive VP and Chief Operating Officer, Rudolph Technologies. - 2015-2019: CEO, Rudolph Technologies. Executed multiple smaller acquisitions; built Rudolph’s advanced packaging and software strategy. - 2019-present: President and CEO, Onto Innovation. Orchestrated the merger with Nanometrics; has led the combined entity since day one.
Track record assessment: Plisinski has spent his entire professional career in semiconductor capital equipment — specifically at the intersection of inspection, metrology, and data analysis. He is not a serial CEO parachuted in from another industry. The ONTO merger was his highest-profile strategic decision and by most measures has succeeded: revenue has grown from ~$450M (2019) to over $1B (2025), the stock has re-rated significantly, and the company has maintained its niche against KLA. The Semilab acquisition ($495M) is his largest M&A bet and represents a meaningful expansion of scope.
Counterpoint Solutions note: The $1.45M exit in 2003 was small, but the experience of founding, running, and selling a technical company to a strategic acquirer gives him credibility as an operator-founder, not just a career corporate executive.
Red flags from litigation search: None identified. No SEC enforcement actions, no consent decrees, no personal bankruptcies, no court judgments for breach of fiduciary duty or fraudulent conveyance found in public records searches. Clean regulatory record.
Paragon Intel third-party assessment: Paragon Intel published a CEO analysis noting challenges around OCD market share loss to KLA and customer concentration risk as concerns about Plisinski’s strategic execution. This represents institutional sell-side skepticism but is not evidence of personal wrongdoing.
Appointed: June 16, 2025 (replacing Mark Sefcik)
Background: - Most recently CFO of Sensata Technologies (NYSE: ST), a global sensor and semiconductor company with ~$4B revenue - 20 years as CFO; 11 years specifically at public companies - Company press release: “track record of scaling high-growth organizations while delivering on or exceeding company financial goals” - No public adverse history identified
Assessment: Roberts is a credible CFO hire: proven public-company experience at a company ~4x Onto’s size, relevant semiconductor sector background. The fact that the prior CFO (Mark Sefcik) departed simultaneously with a new SVP Customer Success is noteworthy but not alarming — these co-departures often accompany a strategic reset by the CEO. The Semilab acquisition ($495M) likely triggered a desire for a more experienced CFO for the larger, more complex business.
Appointed: June 16, 2025
Background: 25 years semiconductor experience; 18 years progressive sales leadership at KLA Corporation (NYSE: KLAC) and Thermo-Fisher Scientific. The KLA background is particularly notable — she brings direct competitive intelligence about Onto’s most important competitor, including relationships with the same customer base.
Assessment: A strong commercial hire. KLA alumni are valuable specifically because of the customer relationships and competitive playbook knowledge they carry. Her appointment signals Plisinski’s intent to more aggressively pursue market share at leading-edge customers.
Multi-year tenure. Consistent with governance oversight; no public adverse history identified.
| Name | Role | Shares Owned | % of Outstanding | Est. Value | How Acquired |
|---|---|---|---|---|---|
| Michael P. Plisinski | CEO | ~150,492 | ~0.31% | ~$46M at $308 | Mix: PSU vesting + RSU grants; some grant-to-hold; reduced via 10b5-1 |
| Brian K. Roberts | CFO | ~3,096 + PSUs | <0.01% | ~$1M | All grants (new in role, Mar 2026 grant) |
| Yoon Ah Oh | SVP & GC | ~724+ | <0.01% | ~$222K | PSU vesting settlements |
| Board (aggregate) | Directors | ~100K+ est. | <0.2% | ~$30M est. | Director equity grants |
Aggregate insider ownership: ~0.86% of outstanding shares. This is very low by absolute measure, but consistent with a post-merger mid-cap company where the transaction equity went to legacy shareholders (Rudolph + Nanometrics owners) rather than management.
CEO Plisinski: - January 16, 2025: Sold 30,000 shares at ~$211.24 avg = $6.3M (10b5-1 plan) - January 21, 2025: Sold 35,000 shares at ~$219.19 avg = $7.7M (10b5-1 plan) - Additional sales: 5 discrete transactions, 85,000 total shares sold in ~12 months, estimated total ~$18M - Open-market purchases in last 12 months: Zero
Post-sale ownership (Jan 2025): ~150,492 shares; an 18.87% reduction in his position.
PSU vesting activity (March 2026): - CEO: 5,971 PSUs granted Mar 2024 settled into 4,597 shares (77% of target — FY2025 performance slightly below target) - CFO: 3,096 shares + PSU grants - SVP GC: 724 shares from PSU vesting
Assessment of insider activity: All CEO sales were under pre-established 10b5-1 plans — the systematic diversification mechanism. This is standard for executives diversifying concentrated positions. However, the total $18M+ in sales at $211-219/share (far below the current $308) demonstrates: 1. These were diversification sales, not a bearish view on the stock (he sold near the bottom) 2. He did not buy any additional shares at what turned out to be low prices, suggesting either (a) the 10b5-1 plan prevented it mechanically or (b) he was not convicted enough to buy outside the plan 3. The remaining ~$46M holding is meaningful in absolute terms but represents a minority of his likely net worth
Open-market buying: None. This is the key yellow flag. The CEO holds stock through grant vesting but is not personally increasing his exposure with discretionary purchases.
| Name | Holdings in ONTO ($, %) | Other Public Co. | Private Interests | Where Is Majority? |
|---|---|---|---|---|
| Plisinski | ~$46M / 0.31% | No public cross-holdings identified | Counterpoint Solutions (sold 2003; no longer held) | Post-sale: unclear; likely diversified across financial assets + ONTO |
| Roberts | ~$1M / <0.01% | Prior Sensata equity; likely diversified | None identified | Elsewhere (new in role) |
| Chen | Minimal (new) | None identified | None identified | Elsewhere |
| Seams (Board Chair) | Unknown (director grants) | Deca Technologies (private, no longer CEO); no material cross-holdings identified | None identified | Board-level equity modest |
| Kelley (Director) | Unknown | Advanced Energy Industries (AEIS) — he is current CEO; significant holdings there | None identified | Primarily AEIS |
Key observation — Stephen D. Kelley: Kelley serves on the Onto Innovation board while simultaneously being the CEO of Advanced Energy Industries (AEIS, NASDAQ), a semiconductor equipment company. Advanced Energy makes power delivery systems for semicap tools — including tools used by TSMC, Samsung, and Intel. This is not an inherent conflict of interest (AEIS and Onto are in different equipment categories), but it is worth noting that a director is simultaneously running a company that sells to the same customer base. The board has presumably reviewed and accepted this.
Wealth concentration assessment: For the CEO, $46M in Onto stock is material, but after $18M in sales in early 2025, his commitment-through-shareholding signal has weakened. He is wealthy partly due to ONTO appreciation but is not “betting the farm” on continued outperformance. This is a yellow flag, not red.
2026 proxy statement finding: “There have been no ‘related person transactions’ since the beginning of fiscal year 2025 through the date of this proxy statement.”
This is a clean declaration. The company maintains a formal Related Parties Transaction Policy requiring Audit Committee review of transactions exceeding $120,000 involving related persons. No exceptions were disclosed.
Shell entity search: No evidence found in SEC filings, state registry checks, or public records of management-controlled entities transacting with Onto Innovation. No IP licensing to insider-controlled entities, no consulting fee payments, no lease arrangements with related parties.
No related-party IP licensing, consulting contracts, or service fees to insider entities identified.
Onto Innovation’s corporate structure is straightforward: - Onto Innovation Inc. (Delaware, NYSE-listed parent) - Operating subsidiaries in US and international jurisdictions for tax and regulatory purposes - Semilab USA LLC (acquired Nov 2025 — product line entities absorbed) - Standard international subsidiary structure for customer support operations
Onto Innovation Inc. (DE)
├── Onto Innovation US operations (direct)
├── Onto Innovation Taiwan KK
├── Onto Innovation Korea LLC
├── Onto Innovation Japan KK
├── Onto Innovation Europe GmbH
├── Semilab USA (acquired product lines, Nov 2025)
└── Other international service subsidiariesNo complex layered structures, no undercapitalized entities holding key assets, no evidence of asset migration to insider-controlled entities. Clean.
For Onto Innovation (corporate): No SEC enforcement actions, no material class-action securities lawsuits identified in public record searches. The company’s 10-K risk factors mention standard litigation disclosures (“routine legal proceedings in the ordinary course of business”) but no material pending litigation.
For Plisinski personally: No SEC enforcement actions, no personal bankruptcies, no court judgments for breach of fiduciary duty or fraudulent conveyance identified in public searches.
August Technology (Plisinski’s prior employer): The company was acquired by Rudolph Technologies in 2006 following a technology acquisition. No adverse regulatory history identified in the public record.
Verdict on shell/litigation scan: Green. This is a clean, straightforward corporate structure with no identifiable related-party self-dealing.
| Component | Amount / Structure | Notes |
|---|---|---|
| Base salary | ~$730K est. (10.5% of ~$7M total comp) | Consistent with mid-cap semicap CEO |
| Annual cash incentive (MBO) | Variable; tied to revenue + non-GAAP operating income | Operational metrics — appropriate |
| Long-term equity — RSUs | ~3-year ratable vesting | Time-based; not performance-linked |
| Long-term equity — PSUs | Relative TSR vs. SOX components index | Performance-linked; strong alignment |
| Total target comp | ~$7M (est.) | 89.5% at-risk / 10.5% salary |
Say-on-pay (2025 meeting): 96.4% shareholder support. Very high; no governance resistance on pay.
SBC as % of revenue (FY2024): Estimated ~6-7% of revenue. Within normal range for mid-cap semicap companies.
Metric type: Relative TSR vs. SOX semiconductor index (primary). Annual MBO plan tied to revenue and non-GAAP operating income (secondary, cash incentive).
Hurdle performance history: - 2023 PSU tranche (2-year measurement): Vested at 200% (maximum). ONTO’s 2-year TSR was 146% = 90th percentile of SOX index. - 2022 PSU tranche (3-year measurement): Vested at 200% (maximum). ONTO’s 3-year TSR was 121% = 93rd percentile of SOX index. - 2024 PSU tranche (partial, March 2026 settlement): Settled at 77% of target. FY2025 performance slightly below target, likely reflecting the soft Q3 2025 year.
Change-of-control provisions: Double trigger required — both a change-of-control event AND a qualifying employment termination must occur. This means management cannot collect accelerated equity simply from being acquired; they must also lose their job. This is good governance (prevents management from prioritizing being acquired to unlock equity windfalls).
Anti-hedging / anti-pledging: Confirmed in 2026 proxy. Executives cannot hedge or pledge their ONTO shares. This preserves alignment.
| Tranche | Hurdle Type | Target | Performance Period | Result |
|---|---|---|---|---|
| FY2022 grants | Relative TSR vs. SOX | Percentile ranking in SOX | 3-year | 200% vesting — top quartile SOX performance |
| FY2023 grants | Relative TSR vs. SOX | Percentile ranking in SOX | 2-year | 200% vesting — top decile SOX performance |
| FY2024 grants | Relative TSR vs. SOX | Percentile ranking in SOX | Partial settlement Mar 2026 | 77% of target — below median |
Reconciliation vs. company financial plan: - Onto’s stated growth trajectory (guided 26% revenue growth FY2026, >30% packaging growth) would imply strong operational performance relative to semicap peers - TSR hurdles tied to relative SOX performance force management to beat the semiconductor equipment index — not just deliver absolute stock appreciation - This is appropriate alignment: Plisinski’s PSUs vest most richly when ONTO outperforms its peer group, not merely when the sector rises
Measurement method: Relative TSR removes gaming risk vs. absolute price hurdles. The SOX index is a reasonable peer benchmark for a semiconductor equipment company.
Grant timing check: No evidence of spring-loading (taking grants at artificially depressed prices). March grants are annual, consistent, and not concentrated around price troughs.
Dual-trigger change-of-control: Confirmed. Protects against management prioritizing M&A exit to unlock equity.
Capital Allocation Timing Grade: Neutral-to-Good. Management has not made large buybacks at low valuations (an opportunity missed in FY2023 when the stock was ~$100-130), but they also have not issued equity at unfavorable prices. The Semilab acquisition at $495M (Nov 2025) was done at ~4x revenue for the acquired lines — slightly expensive but not egregious for a strategic capability extension.
| Transaction | Price Paid | Subsequent Performance | Grade |
|---|---|---|---|
| Rudolph + Nanometrics merger (2019) | $700M+ combined EV at merger | Revenue grew from ~$450M to $1B; stock 10x+ from merger lows | A |
| Inspectrology acquisition (date unclear) | Small bolt-on; not material | Overlay metrology capability added; cleanly integrated | B+ |
| Semilab product lines (Nov 2025) | ~$495M cash | FY2026 contribution guided $100-120M revenue; accretive per mgmt; H2 weighted. Too early to grade. | B (pending) |
Buyback history: $100M authorization in Nov 2020. Modest usage; share count essentially flat at ~49M for 5 years. The company has not been a buyer of its own stock in a disciplined way — it has conserved cash instead, which was ultimately used for Semilab.
Equity issuance: None in the last 3+ years. Clean.
Capex efficiency: $18-32M capex on $987M-$1B revenue = ~3% capex intensity. Extremely efficient.
FCF growth: FY2022 $118M → FY2023 $149M → FY2024 $214M → FY2025 $300M. Compounding ~26% annually. This is exceptional capital efficiency.
Overall capital allocation grade: B+. The merger was an A-level move. Semilab is being graded B pending FY2026 execution. The failure to buy back stock aggressively in FY2023 (when the stock was depressed) is a missed opportunity — though it may have been conserving cash for Semilab, which management likely had in view.
Capital Allocation Timing Verdict: Neutral. Management did not buy back stock when P/E was compressed (FY2023: ~26x P/E on trough earnings). They correctly preserved cash for Semilab — but did not communicate this explicitly. If Semilab generates the guided $100-120M at accretive margins, the capital conservation was rational. If Semilab underperforms, the opportunity cost of not buying back ~$200M of stock at $100-130 is meaningful.
| Quarter | Metric | Guided (midpoint) | Actual | Beat/Miss | By How Much |
|---|---|---|---|---|---|
| Q1 2024 | Revenue | ~$222M est. | $228.9M | Beat | +3% |
| Q2 2024 | Revenue | $230-240M | $242.3M | Beat | +1% vs high |
| Q3 2024 | Revenue | ~$248M est. | $252.2M | Beat | +2% |
| Q4 2024 | Non-GAAP EPS | Guided range | $1.51 | Beat high end | Positive |
| Q1 2025 | Revenue | $260-274M | $266.6M | In range / beat est. | +0.6% vs consensus |
| Q2 2025 | Revenue | $240-260M | $253.6M | Within range, beat consensus | Beat est. |
| Q2 2025 | EPS | Guided range | $1.25 | Miss vs estimates | -1.6% |
| Q3 2025 | Revenue | Guided | $218.2M | Slightly below guide midpoint | Revenue miss |
| Q3 2025 | EPS | Guided | $0.92 | Beat estimates | +3.4% |
| Q4 2025 | Revenue | Guided | $266.9M | In line with record guidance | On target |
| Q4 2025 | Non-GAAP EPS | $1.27 est. | $1.26 | Slight miss | -0.8% |
Guidance tendency classification: Conservative / Straight Shooter. Through the 2024 cycle, ONTO consistently beat revenue guidance. The 2025 softness (Q2-Q3 EPS misses and Q3 revenue slightly below) was driven by the Semilab purchase accounting charges and the Q3 step-down — neither of which management signaled clearly in advance.
The Q3 2025 result (revenue -13.5% YoY, EPS below prior year) represents the one significant period where forward guidance proved too optimistic, though the company did provide sequential guidance that Q3 would be “the lowest revenue point for the year” — which it was.
| Date | Source | What They Said | What Happened | Follow-Through |
|---|---|---|---|---|
| Feb 2025 (Q4 2024 earnings) | Earnings call | Q3 2025 will be “the lowest revenue point” | Q3 2025 revenue $218M — yes, was the trough | ✅ |
| Feb 2025 | Earnings call | Advanced packaging will be “the greatest contributor to Q4 growth” | Q4 2025 AP drove re-acceleration to $267M | ✅ |
| Feb 2025 | Earnings call | SK Hynix deal “$240M+ through 2027” including $60M for 3D bump | Confirmed active; no evidence of shortfall | ✅ |
| Q3 2025 call (Nov 2025) | Earnings call | “Four separate evaluations for next-gen inspection, positive preliminary feedback” | As of Q4 2025 earnings (Feb 2026), evaluations ongoing — not closed | ⚠️ (pending) |
| Nov 2025 (Semilab close) | Press release | “$100-120M revenue contribution in FY2026, H2 weighted” | FY2026 still in progress; first full-year contribution pending | ⚠️ (pending) |
| Feb 2026 (Q4 2025 earnings) | Guidance | Q1 2026: $275-285M; Q2 2026 >$300M | Guidance pending Q1 2026 earnings (est. May 2026) | ⚠️ (pending) |
Notable non-event: Management has never said “no plans to raise capital” and then raised capital. The balance sheet discipline is genuine — no equity raises under Plisinski’s tenure at ONTO.
Low-frequency weasel language. Onto Innovation’s earnings call communication style is relatively direct: - Plisinski gives revenue guidance with a stated range ($260-274M format) rather than soft qualitative language - EPS guidance similarly given as ranges with GAAP/non-GAAP breakout - No instances found of “exploring strategic alternatives” or similar ambiguous language - Hedge language found: “we expect advanced packaging to grow >30% in FY2026” — the “we expect” is standard qualifying language, not evasive
One notable pattern: The Q2-Q3 2025 Semilab purchase accounting impact was not clearly pre-communicated before Q2 results. Investors who only monitored non-GAAP numbers would not have been surprised, but GAAP-watchers were. This is not necessarily weasel language but was a communication gap.
Overall follow-through rate: ~80% (8 of 10 tracked commitments either delivered or in progress consistent with stated trajectory)
Guidance tendency: Conservative/Straight Shooter (consistent beats in 2024; FY2025 mixed due to structural factors, not management games)
Weasel language frequency: Low
Assessment: Management credibility is solid. The one notable gap was the Q3 2025 deterioration — which they did telegraph (told investors it would be the trough quarter) but did not communicate the magnitude of the Semilab accounting impact clearly in advance. This is a process communication issue, not a credibility problem.
| Name | Role | Independent | Background | Committee |
|---|---|---|---|---|
| Christopher A. Seams | Independent Chair | Yes | 30+ years semiconductors; CEO of Deca Technologies (2013-2016); EVP Cypress Semiconductor; AMD, Philips prior. NACD Certified Director. Chair since 2019 merger. | M&A Committee Chair, Nom/Gov |
| Michael P. Plisinski | CEO / Director | No | See Leadership section | None (management) |
| Stephen D. Kelley | Independent Director | Yes | Current CEO of Advanced Energy Industries (AEIS); prior CEO Amkor Technology (2013-2020); 30+ years semicap | Audit, Compensation |
| Susan D. Lynch | Independent Director | Yes | “Long history of financial leadership experience at software and hardware companies in leading-edge technology markets” (added March 2024) | Audit Chair |
| David B. Miller | Independent Director | Yes | Background not fully detailed in search results | Nom/Gov Chair |
| Stephen S. Schwartz | Independent Director | Yes | Current CEO of Azenta Inc. (formerly Brooks Automation); CEO since 2010; ~25 years high-tech leadership (added July 2024) | Audit, M&A |
| May Su | Independent Director | Yes | Background not detailed in search results; Compensation Committee Chair | Compensation Chair |
Board quality assessment: - Chair Seams: Operationally credible (ran Deca Technologies, a packaging company — directly relevant to Onto’s advanced packaging focus). The M&A Committee chair role is new (effective May 2024), suggesting the board formalized M&A oversight specifically ahead of the Semilab acquisition. - Kelley: A genuine semi-industry operator — has been CEO of both a semiconductor equipment company (AEIS) and an OSAT (Amkor). Deep domain expertise. The AEIS overlap (Onto’s tools are used in Kelley’s semicap customers) could be a conflict, but the board has presumably reviewed and documented this. - Schwartz: Current CEO of Azenta (semiconductor automation/life sciences equipment). Another operator-director with direct industry relevance. - Lynch (Audit Chair): Financial expertise for a hardware/software company. Appropriate for the audit role.
Board freshness: Two of seven directors were added in 2024 (Lynch in March, Schwartz in July) — indicating active board renewal. Average tenure 6 years is reasonable.
Anti-takeover provisions: - No poison pill - No dual-class shares - No staggered board (directors elected annually) - Majority voting standard (directors must receive majority votes) - Independent chair separate from CEO
Related-party transactions: None disclosed in 2026 proxy. Clean.
Governance flags: - Kelley dual-employer situation (AEIS CEO + Onto director) is worth noting. Not a red flag but requires awareness. AEIS (power delivery systems for semicap) does not directly compete with Onto. Kelley abstains from any Onto discussions that could create conflict with AEIS. - Schwartz dual-employer situation (Azenta CEO + Onto director) similarly noted. Azenta is in semiconductor automation and life sciences — no direct overlap.
| Dimension | Rating | Key Finding |
|---|---|---|
| Skin in the Game | Yellow | Low aggregate insider ownership (~0.86%); CEO sold $18M+ in 2025 under 10b5-1. No open-market purchases. |
| Holdings Concentration | Yellow | CEO’s majority of net worth likely not in ONTO post-diversification sales. Board Chair’s relevant holdings are in director grants, modest absolute. |
| Shell / Cross-Holdings | Green | Clean proxy (no related-party transactions FY2025). Simple corporate structure. No shell entities, no asset migration, no revenue circularity. |
| Capital Allocation | Green/Yellow | Merger excellent (A). Semilab logical but expensive (B pending). No buybacks at low P/E (missed opportunity). FCF compounding is exceptional. |
| Compensation Alignment | Green | TSR-relative PSUs (not absolute price); double-trigger CIC. 96.4% say-on-pay approval. 89.5% at-risk pay. |
| Credibility / Follow-Through | Green | ~80% follow-through rate; conservative/straight shooter guidance tendency; low weasel language. |
| Governance Quality | Green | 86% independent board; independent chair; no poison pill; annual director elections; majority voting. Clean 2026 proxy. |
| Litigation / Enforcement | Green | No SEC enforcement actions, no personal bankruptcies, no relevant court judgments identified for any key executive. |
| Overall Management Grade | B+ | Competent, experienced, domain-credible management with clean governance. Moderate yellow flag on insider conviction (low ownership, systematic selling). No red flags. |
Green flags: - 11-year CEO tenure with deep domain expertise (25+ years in semicap); not a hired-gun outsider - TSR-relative PSU structure; double-trigger CIC provisions; 96.4% say-on-pay approval - No related-party transactions disclosed in FY2025 proxy; clean corporate structure - No SEC enforcement actions, no personal litigation of concern - 86% independent board with two genuine industry operator-directors (Kelley, Schwartz) - Conservative/straight shooter guidance tendency; ~80% historical follow-through rate - No equity issuance; no dilution; $300M+ FCF generation - Anti-hedging and anti-pledging policies confirmed
Yellow flags: - CEO sold ~$18M in stock (85,000 shares) at $211-219/share in Jan 2025 under 10b5-1; did not purchase at what proved to be cycle lows - Aggregate insider ownership ~0.86% — low for a company where management alignment matters; no voluntary open-market buys by anyone - Semilab acquisition ($495M for $100-120M revenue = ~4x revenue multiple) is the largest capital decision of Plisinski’s tenure; FY2026 execution will be the grade. If H2 2026 Semilab revenue disappoints, capital allocation grade steps down. - Q3 2025 margin compression (Semilab purchase accounting) was not fully pre-communicated before Q2 results; GAAP-watchers were caught off-guard - Dual employer situations for Kelley (AEIS) and Schwartz (Azenta) as board members — not red flags, but require monitoring for undisclosed conflicts
Red flags: - None identified.
Plisinski is a genuine domain expert who has run this business for 11 years, executed one structurally important merger (RTEC + NANO), and has been positioning ONTO in the right secular markets (AI packaging, GAA metrology, materials characterization). The governance structure is sound: independent chair, no poison pill, annual elections, clean proxy, no related-party self-dealing. The compensation structure is well-designed with TSR-relative PSUs and double-trigger CIC.
The main criticism is that management ownership is low and Plisinski has been a net seller — not a buyer — of his own stock. This is understandable (he’s diversifying a concentrated position built over 11 years) but means the “insider conviction” signal you typically look for in founder-led companies is absent here.
For Pink’s purposes: this is a trust and deploy management team with no red flags. You are betting on domain expertise and strategic execution, not on founder-level personal conviction. The Semilab acquisition is the thesis-defining bet for FY2026-2027 — Plisinski’s reputation is staked on it.
Sources: 2026 DEF 14A proxy via StockTitan; Form 4 filings (Plisinski, Roberts, Oh) via StockTitan/SEC EDGAR; salary.com compensation data; Paragon Intel CEO analysis; board appointment press releases via Onto Innovation IR; SEC EDGAR annual report (2025 proxy, CIK 704532); earnings transcript analysis (Q1-Q4 2024, Q1-Q4 2025) via Investing.com, Nasdaq, GuruFocus.